Predicting Diagnostic Gene Biomarkers for Non-Small-Cell Lung Cancer

被引:9
|
作者
Liang, Bin [1 ]
Shao, Yang [1 ]
Long, Fei [1 ]
Jiang, Shu-Juan [1 ]
机构
[1] Shandong Univ, Shandong Prov Hosp, Dept Resp Med, Jinan 250021, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
EXPRESSION; NETWORK; GEMCITABINE; PROTEINS; DATABASE; PATHWAY; RISK;
D O I
10.1155/2016/3952494
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Lung cancer is the primary reason for death due to cancer worldwide, and non-small-cell lung cancer (NSCLC) is the most common subtype of lung cancer. Most patients die from complications of NSCLC due to poor diagnosis. In this paper, we aimed to predict gene biomarkers that may be of use for diagnosis of NSCLC by integrating differential gene expression analysis with functional association network analysis. We first constructed an NSCLC-specific functional association network by combining gene expression correlation with functional association. Then, we applied a network partition algorithm to divide the network into gene modules and identify the most NSCLC-specific gene modules based on their differential expression pattern in between normal and NSCLC samples. Finally, from these modules, we identified genes that exhibited the most impact on the expression of their functionally associated genes in between normal and NSCLC samples and predicted them as NSCLC biomarkers. Literature review of the top predicted gene biomarkers suggested that most of them were already considered critical for development of NSCLC.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Cisplatin and gemcitabine in non-small-cell lung cancer
    Cartei, G
    Sacco, C
    Sibau, A
    Pella, N
    Iop, A
    Tabaro, G
    ANNALS OF ONCOLOGY, 1999, 10 : 57 - 62
  • [22] C10ORF97 is a novel tumor-suppressor gene of non-small-cell lung cancer and a functional variant of this gene increases the risk of non-small-cell lung cancer
    Shi, Y.
    Chen, J.
    Li, Z.
    Zhang, Z.
    Yu, H.
    Sun, K.
    Wang, X.
    Song, X.
    Wang, Y.
    Zhen, Y.
    Yang, T.
    Lou, K.
    Zhang, Y.
    Zhang, G.
    Hu, Y.
    Ji, J.
    Hui, R.
    ONCOGENE, 2011, 30 (39) : 4107 - 4117
  • [23] MicroRNAs as early diagnostic biomarkers for non-small cell lung cancer (Review)
    Liang, Xindi
    Wu, Qiang
    Wang, Yuan
    Li, Shirong
    ONCOLOGY REPORTS, 2023, 49 (01)
  • [24] Metformin synergistic pemetrexed suppresses non-small-cell lung cancer cell proliferation and invasion in vitro
    Zhang, Yan
    Feng, Xiuli
    Li, Tao
    Yi, Erpan
    Li, Yu
    CANCER MEDICINE, 2017, 6 (08): : 1965 - 1975
  • [25] Gemcitabine in the treatment of non-small-cell lung cancer
    Burkes, RL
    Shepherd, FA
    ANNALS OF ONCOLOGY, 1995, 6 : 57 - 60
  • [26] EGFR mutations in non-small-cell lung cancer
    Hung, Jung-Jyh
    Jeng, Wen-Juei
    Hsu, Wen-Hu
    Liu, Jung-Sen
    Wu, Yu-Chung
    LANCET ONCOLOGY, 2010, 11 (05) : 412 - 413
  • [27] Application of proteomics in non-small-cell lung cancer
    Cho, William C. S.
    EXPERT REVIEW OF PROTEOMICS, 2016, 13 (01) : 1 - 4
  • [28] WWOX gene may contribute to progression of non-small-cell lung cancer (NSCLC)
    Baykara, Onur
    Demirkaya, Ahmet
    Kaynak, Kamil
    Tanju, Serhan
    Toker, Alper
    Buyru, Nur
    TUMOR BIOLOGY, 2010, 31 (04) : 315 - 320
  • [29] Polymorphisms of EpCAM gene and prognosis for non-small-cell lung cancer in Han Chinese
    Yang, Yuefan
    Fei, Fei
    Song, Yang
    Li, Xiaofei
    Zhang, Zhipei
    Fei, Zhou
    Su, Haichuan
    Wan, Shaogui
    CANCER SCIENCE, 2014, 105 (01) : 89 - 96
  • [30] The Role of the Selected miRNAs as Diagnostic, Predictive and Prognostic Markers in Non-Small-Cell Lung Cancer
    Szczyrek, Michal
    Bitkowska, Paulina
    Jutrzenka, Marta
    Milanowski, Janusz
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (08):